ACS Clinical Research Program
The study design of the OPRA Trial, which includes a watch-and-wait cohort for locally advanced rectal cancer, is summarized.
The ACS CRP will offer sessions at Clinical Congress 2019 on the topics of developing clinical trial and decreasing administrative burden associated with those trials.
Clinical trial data are examined to help develop a consensus approach for locally advanced gastric cancer.
Smoking cessation intervention trials examine potential outcome improvements for lung cancer patients.
Atezolizumab in the adjuvant treatment of stage III colon cancer: Can PD-L1 inhibition improve survival?
The study design for the ATOMIC trial (Alliance A021502), a randomized phase III study examining atezolizumab treatment of stage III colon cancer, is described.
More in this category
- Cytoreduction with or without HIPEC: Where do we go from here?
- Robotic surgery for hepatic neoplasms: Where does it fit in the minimally invasive surgery landscape?
- Surveillance testing for colorectal cancer: New evidence supports a change in guidelines
- Colorectal cancer in adults younger than 50 years old
- The evolving clinical management of sentinel node-positive melanoma: The impact of MSLT-II on clinical practice
- Liquid biopsies in cancer clinical trials
- Geriatric assessment and frailty in older cancer patients
- Immunotherapy in solid tumors
- Duration of adjuvant therapy for stage III colon cancer: No longer one size fits all
- Adjuvant therapies for biliary tract cancers
- Improving surgical care and outcomes through the OPTI-Surg toolkit
- Surgical management of ADH, ALH, and LCIS
- Clinical trials for surgeons: Hurdles and opportunities
- Present and future cancer staging with the eighth edition of the AJCC Cancer Staging Manual
- Induction chemotherapy and minimally invasive transanal surgery to increase organ preservation in rectal cancer